Physical and functional interaction between WT1 and p53 proteins.
- 1 June 1993
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 90 (11) , 5100-5104
- https://doi.org/10.1073/pnas.90.11.5100
Abstract
WT1 is a tumor-suppressor gene expressed in the developing kidney, whose inactivation leads to the development of Wilms tumor, a pediatric kidney cancer. WT1 encodes a transcription factor which binds to the EGR1 consensus sequence, mediating transcriptional repression. We now demonstrate that p53, the product of a tumor-suppressor gene with ubiquitous expression, physically associates with WT1 in transfected cells. The interaction between WT1 and p53 modulates their ability to transactivate their respective targets. In the absence of p53, WT1 acts as a potent transcriptional activator of the early growth response gene 1 (EGR1) site, rather than a transcriptional repressor. In contrast, WT1 exerts a cooperative effect on p53, enhancing its ability to transactivate the muscle creatine kinase promoter.This publication has 21 references indexed in Scilit:
- Regulation of the Human hsp70 Promoter by p53Science, 1993
- Repression of the Insulin-Like Growth Factor II Gene by the Wilms Tumor Suppressor WT1Science, 1992
- Retinoblastoma protein switches the E2F site from positive to negative elementNature, 1992
- Modulation of DNA Binding Specificity by Alternative Splicing of the Wilms Tumor wt1 Gene TranscriptScience, 1992
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.Genes & Development, 1991
- Binding of the Wilms' Tumor Locus Zinc Finger Protein to the EGR-1 Consensus SequenceScience, 1990
- Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53Science, 1990
- An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumorCell, 1990
- Point Mutational Inactivation of the Retinoblastoma AntioncogeneScience, 1989